High pollution may boost demand for respiratory drugs

"The respiratory market shows the normal seasonal trend for the anti-asthma and cough and cold segment," said Sheetal Sapale, VP, commercial, Pharmarack. "There were fewer reported cases in October 2024 compared to October 2023, hence there is de-growth in the market. The market peaks in December and January and then gradually subsides as winter loses its intensity," Sapale said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qt0vgsj
via IFTTT